Louise Rodino-Klapac - President, R&D and Tech Ops at Sarepta Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, R&D and Tech Ops
Issuer Symbol
SRPT on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Louise Rodino-Klapac since 12 Mar 2025

Holdings reported by Louise Rodino-Klapac for Sarepta Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 226,271 $4,186,013 $18.50 09 Mar 2026 Direct
Performance Stock Units 0 $0 $100.13 01 Mar 2026 Direct Common Stock
Stock Options (right to buy) 16,644 10 Mar 2025 Direct Common Stock

Transactions reported by Louise Rodino-Klapac for Sarepta Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.